ARTICLE
9 January 2019

Womble Bond Dickinson's Heather Hatcher Co-Authors Journal Of Clinical And Translational Science Article On Regulatory Issues In Additive Manufacturing (3D Printing)

WB
Womble Bond Dickinson

Contributor

Being different is our normal way of working. It's not just what we do, it's how we do it.

You'll benefit from more than just the skills and know-how you'd expect from a pioneering law firm; our technology specialists, process and project management leaders, accountants and tax advisers work alongside lawyers with specialist sector expertise – from business to government.

Working side by side, we'll find clever solutions to your age-old problems.

With 1,300 professionals across 39 offices in the US and UK, we're equipped to tackle mission-critical challenges, wherever you do business.

Want the proof? It's in our track record. With our straight-talking, entrepreneurial approach, we’ve set new industry precedents, achieved market firsts and delivered trailblazing work for our clients.

So, whatever your future holds, we're here for you with A Point of View Like No Other.

WINSTON-SALEM, NC - Advances in technology often outpace the ability of regulatory bodies to keep up with the latest breakthroughs. When products regulated by the Food and Drug Administration (FDA)
United States Food, Drugs, Healthcare, Life Sciences
Womble Bond Dickinson are most popular:
  • within Law Department Performance, Insurance and Immigration topic(s)
  • with Senior Company Executives and HR
  • with readers working within the Construction & Engineering industries

WINSTON-SALEM, NC - Advances in technology often outpace the ability of regulatory bodies to keep up with the latest breakthroughs. When products regulated by the Food and Drug Administration (FDA) are involved, product manufacturers can struggle to find the appropriate regulatory pathways for evolving technologies.

Womble Bond Dickinson Regulatory Scientist Heather Hatcher, Ph.D., has co-authored a recent article on regulatory science issues surrounding the FDA-regulated additive manufacturing (or 3D printing) of medical products. The article was published online November 29, 2018 in the Journal of Clinical and Translational Science.

The article stems from a discussion at the 2017 Fall Forum of the Regulatory Science to Advance Precision Medicine Working Group in Washington, DC.

Co-authors of this article with Dr. Hatcher included Joan Amado and Scott Steele of the University of Rochester Medical Center's Clinical & Translational Science Institute; Warren Grayson of the Translational Tissue Engineering Center at the Johns Hopkins University School of Medicine; Jennifer Swanton Brown of the Stanford Center for Clinical & Translational Research & Education; Andrika Thomas of Weill Cornell Medicine's Core Laboratory of the Clinical & Translational Science Center; and Scott Hollister of the Center for 3D Medical Fabrication and Department of Biomedical Engineering at the Georgia Institute of Technology/Emory University.

Click here to download and read " Regulatory Interfaces Surrounding the Growing Field of Additive Manufacturing of Medical Devices and Biologic Products".

Heather Hatcher, Ph.D., is a regulatory scientist with the Womble Bond Dickinson Regulatory Affairs Advance Service Team. Drawing on her background as a research scientist, Dr. Hatcher provides strategic regulatory guidance to clients in the pharmaceutical and medical device industries.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

[View Source]

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More